This site may earn chapter commissions from the links on this page. Terms of employ.

Jeff Bezos and a cabal of billionaires surprised everyone last month with the annunciation that they're conspiring to disrupt the healthcare manufacture. They are planning to offer a "not-for-profit" system that would initially be made bachelor to employees of their respective companies, but with the potential to exist rolled out to Americans en masse. It's non the first fourth dimension a group of über-wealthy, revolutionary-minded individuals take plotted to overthrow a tyrannical arrangement. Just references to America's founding fathers bated, 1 outstanding question remains: How will these visionaries slay the merciless beast that the American healthcare organisation has become?

One thing is nearly assured: Given their respective companies and interests, a heavy dose of engineering science will likely figure into the mix. Let'southward risk a few guesses as to what ingredients we may see in this healthcare system of the future. We'll round up some of the usual suspects from the health tech industry, and come across how they are likely to play a function in the Bezos-Buffet-Dimon model.

The End of the Waiting Room

Waiting to be seen by a doctor is both a nuisance and a drag on the economy. In general, you're likely to spend fifteen to 30 minutes in the waiting room on a typical part visit, to say null of the commute. In render yous're lucky if you get a paltry 5 minutes of the doctor's time. That means for every one hour of a medico's time, the sick must spend upwards of six hours waiting for them. In the equation of sick people versus healthy ones, this places the greater burden upon those who are already feeling miserable, a miscarriage of justice of ever there was one.

The fix is already out there; in most cases, telemedicine tin can supervene upon the current office-visit model. At least initially, nosotros're probable to meet this mode of diagnosis playing a major function in the Bezos-Buffet-Dimon model. In the long run, though, fifty-fifty telemedicine is likely to get muscled out past AI-driven diagnostic systems, eliminating the general practitioner as gatekeeper for those who need a specialist or laboratory tests. In the future, such inefficiencies will be eliminated, as artificial intelligence will excel compared with man doctors at almost every form of diagnostic intervention.

Liberating Patient Data

Currently most of a patient's health information remains siloed in vendor-specific data chambers. Similar avaricious goblins hoarding their plunder, companies similar Ballsy Systems have stockpiled patient data, refusing to plant the interoperability standards that would permit patients and other health intendance operators to make the best employ of this treasure trove. The ultimate victims have been the patients themselves, who often notice themselves spending hours on the telephone between specialists trying to make sure their files get to the right person at the right time.

Tech companies like Amazon accept typically eschewed company-specific standards, every bit they human action as a kind of bottleneck on information menstruation. Instead, the tech industry has embraced APIs, or application programming interfaces, which allow for data to be safely shared betwixt systems. Interoperability standards volition be a big role of the Bezos-Cafe-Dimon model, and clients should take much more timely access to their information. Anything less would be a blemish on the new arrangement.

Cutting out the Middleman

Amazon has made a science of cutting out the middleman, eliminating many of the brick and mortar stores that offered similar goods to the internet giant. While in that location may be proficient reason to mourn the loss of mom-and-pop bookstores, stores that suffered in the Amazon era, I can find no cause for sympathy for Walgreens and CVS. Pharmaceutical dispensaries such as these are likely to exist cut out of a new health care model, with lower costs passed on to the patients themselves. But should you find yourself feeling a twinge of remorse for CEO Larry Merlo of CVS, who took home a cool xviii million dollars in salary terminal twelvemonth, no doubt a clemency can be established in his name to benefit struggling CEOs.

Getting the Genomics Revolution Underway

At that place is a tranquillity revolution underway in the medical field thank you to the confluence of bogus intelligence, Big Data, and genomics. This goes well across the direct-to-consumer reports offered past companies similar 23andMe. The genomics revolution will affect everything from the vetting of prescription drugs to how nosotros cull which vitamins to accept. Unfortunately, well-nigh of these advances have withal to trickle downwardly to doctors offices in the Usa, where your average family practitioner is completely uninformed most their patients' genetics. Amazon, every bit a pioneer of big data and bogus intelligence, is likely to bring their muscle into play, making genomics a bigger part of the patient experience.

tricorder

Dynamical Biomarkers Grouping fielded the T06, their tricorder prototype. Image credit: XPrize

These are merely a handful of the changes we can wait to see in the Bezos-Buffet-Dimon model, with fifty-fifty more drastic disruption probable to take place every bit gadgets like the tricorder make their fashion into the hands of patients and doctors. But perhaps the most pressing question is the one left unaddressed. The tool nominally responsible for encouraging this kind of healthcare innovation is itself malfunctioning; we're left relying on the good will of billionaires to do what is arguably the job of government. What practice you practise when the institution overseeing the healthcare industry is then intertwined with the special interest groups belongings the arrangement dorsum that it cannot exist relied upon to brand the kind of substantial changes that would improve outcomes for patients?

Another, much older group of revolutionary-minded Americans had something to say on that score. To quote Henry David Thoreau: "There are a thousand hacking at the branches of evil to one who is striking at the root." Wherever Bezos and his comrades fall upon this calibration of intervention, we can be glad they have taken an interest in changing what is obviously one of the most perniciously cleaved sectors of the American economy.